Patent · US Active

Compounds for use in the treatment of bacterial infection

US9127035B2 · kind B2 · utility

2Cited by

1References

16Claims

0Family size

Assignee

The Royal Institution for the Advancement of Learning/McGill University · CA

Inventors

Karine Auclair · Laval, CA
Kenward Vong · Toronto, CA

Key dates

Filing date	Jan 17, 2012
Grant date	Sep 8, 2015
Priority date	—
Expiry date	Jan 26, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07H15/234
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to a compound of Formula 1A:or a pharmaceutically acceptable salt thereof; wherein R1 to R4, R7, R9 to R12 and Y are as defined herein. The invention further relates to pharmaceutical composition comprising said compound or a pharmaceutically acceptable salt thereof; and method of using same for reducing or reversing bacterial resistance to at least one aminoglycoside antibiotic.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.